Novartis AG (NVS)
NYSE·Healthcare·Drug Manufacturers - General
$156.76
+1.91%
Mkt Cap $314.69B
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$170.00
Range $170.00 – $170.00
Implied Upside
+8.4%
Consensus $170.00 vs current $156.76
NYSE·Healthcare·Drug Manufacturers - General
$156.76
+1.91%
Mkt Cap $314.69B
No recent rating data.
Price Target (8 analysts)
$170.00
Range $170.00 – $170.00
+8.4%
Consensus $170.00 vs current $156.76